The first FDA-approved clinical trial of psilocin has begun

Freethink

July 19, 2022

read more News

Filament Health Announces Issuance Of Common Shares To Negev Capital Investments Limited Pursuant To Advisory Agreement

Filament Health Announces Second Quarter 2024 Financial Results And Operational Highlights